Comorbidities: Should cancer screening be routine in rheumatoid arthritis?

Eric L. Matteson

doi:10.1038/nrrheum.2009.173

Comorbidities: Should cancer screening be routine in rheumatoid arthritis?

Research output: Contribution to journal › Article › peer-review

Abstract

The degree to which the elevated risk of malignant lymphomas in patients with rheumatoid arthritis (RA) is related to disease activity or to therapy is uncertain. evidence is mounting in support of a strategy of more-intensive cancer screening in these patients.

Original language	English (US)
Pages (from-to)	474-475
Number of pages	2
Journal	Nature Reviews Rheumatology
Volume	5
Issue number	9
DOIs	https://doi.org/10.1038/nrrheum.2009.173
State	Published - Sep 2009

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1038/nrrheum.2009.173

Cite this

@article{b623db9b828f48ed8f2a61d0b6e5a637,

title = "Comorbidities: Should cancer screening be routine in rheumatoid arthritis?",

abstract = "The degree to which the elevated risk of malignant lymphomas in patients with rheumatoid arthritis (RA) is related to disease activity or to therapy is uncertain. evidence is mounting in support of a strategy of more-intensive cancer screening in these patients.",

author = "Matteson, {Eric L.}",

year = "2009",

month = sep,

doi = "10.1038/nrrheum.2009.173",

language = "English (US)",

volume = "5",

pages = "474--475",

journal = "Nature Reviews Rheumatology",

issn = "1759-4790",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Comorbidities

T2 - Should cancer screening be routine in rheumatoid arthritis?

AU - Matteson, Eric L.

PY - 2009/9

Y1 - 2009/9

N2 - The degree to which the elevated risk of malignant lymphomas in patients with rheumatoid arthritis (RA) is related to disease activity or to therapy is uncertain. evidence is mounting in support of a strategy of more-intensive cancer screening in these patients.

AB - The degree to which the elevated risk of malignant lymphomas in patients with rheumatoid arthritis (RA) is related to disease activity or to therapy is uncertain. evidence is mounting in support of a strategy of more-intensive cancer screening in these patients.

UR - http://www.scopus.com/inward/record.url?scp=70350495619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350495619&partnerID=8YFLogxK

U2 - 10.1038/nrrheum.2009.173

DO - 10.1038/nrrheum.2009.173

M3 - Article

C2 - 19710668

AN - SCOPUS:70350495619

SN - 1759-4790

VL - 5

SP - 474

EP - 475

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

IS - 9

ER -

Comorbidities: Should cancer screening be routine in rheumatoid arthritis?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this